Naoya Kato joined IDEC (now ELIQUENT Japan, Inc.) in 2008, following a distinguished career of global drug development experience.

Mr. Kato has more than 30 years experience working with large multi-national pharmaceutical companies.

He has broad experience in global drug development with particular expertise in the clinical and regulatory management of the global regulatory strategy integrating Japan into global product development programs.

With his broad experience in the regulatory science for the development of global product development strategies, he achieved several successful globally integrated programs involving Japan by leading global project teams. He has contributed to the clients’ successful attainment of marketing approvals ahead of schedule. Leveraging his extensive skills and experience, the clients have overcome various obstacles and, in some cases, obtained marketing approvals simultaneously in Japan, the US, and Europe.